// App-Quantinova.ai

688 : Factors predicting patient satisfaction with botulinum toxin treatment in cervical dystonia patients who have been treated for a year

Researchers

Presenter

  • V. Misra

Principal Investigators

  • C. Colosimo

  • T. Chung

  • D. Charles

  • S. Om

  • P. Maisonobe

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Cervical dystonia

Biomarkers

  • Cluster of Differentiation 2

Drug/Treatment

  • Botox

  • AbobotulinumtoxinA

  • Botulinum toxin A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • NCT01753349

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved